

share
Hemoglobin F Seattle CAS NO 119322-29-1
Unit Price:
CAS No.:119322-29-1
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Hemoglobin F Seattle CAS NO 119322-29-1 is a specific variant of fetal hemoglobin, a critical protein for oxygen transport. This compound is of significant interest in biochemical research and diagnostic development due to its unique structural properties. It is primarily utilized by researchers in hematology, clinical diagnostics, and pharmaceutical development for studying hemoglobinopathies and developing targeted therapeutic and analytical applications.
Application
- Biochemical Research Standard: Used as a reference material in studies of fetal hemoglobin structure, function, and genetic variants.
- Diagnostic Assay Development: Serves as a key component in the calibration and validation of diagnostic tests for sickle cell disease and thalassemia.
- Therapeutic Protein Studies: Employed in research focused on developing hemoglobin-based oxygen carriers (HBOCs) and gene therapies.
- Clinical Laboratory Testing: Used as a control or calibrator in high-performance liquid chromatography (HPLC) and mass spectrometry methods for hemoglobin analysis.
- Educational & Training Material: Provides a specific example for academic and professional training in clinical chemistry and molecular biology.
Basic Information
| Product Name | Hemoglobin F Seattle |
| CAS No. | 119322-29-1 |
| Molecular Formula | Contact for details |
| Molecular Weight | Contact for details |
| Synonyms | Hb F Seattle; Fetal Hemoglobin Seattle; γ-Globin Variant Seattle; Hemoglobin F (Seattle); Gly->Asp variant at γ-136; HbF Seattle variant; Fetal hemoglobin (Seattle type) |
| EINECS | Contact for details |
Quality Control
Our Hemoglobin F Seattle is produced and handled under stringent quality protocols suitable for research and diagnostic applications. Each batch undergoes rigorous analytical testing to ensure identity, purity, and stability. A comprehensive Certificate of Analysis (COA) detailing purity (by HPLC), identity confirmation, and other relevant parameters is available upon request to support your quality assurance requirements.
Storage
Preserve in a tightly closed container, protected from light. Store at 2-8°C for long-term stability. This product is hygroscopic (moisture-sensitive); ensure the container is sealed tightly after each use to minimize exposure to atmospheric moisture. For extended storage, consider aliquoting and freezing at -20°C or below under inert conditions.
Specification
| Item | Specification |
|---|---|
| Appearance | Lyophilized powder |
| Identification (HPLC/MS) | Conforms to standard for Hb F Seattle |
| Purity (HPLC) | ≥ 95% |
| Solubility | Soluble in aqueous buffers |
| Protein Content (Biuret) | ≥ 90% |
| Moisture Content (KF) | ≤ 5.0% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Bovine Albumin CAS NO 9048-46-8


Albumin From Chicken Egg White CAS NO 9006-59-1


Dermorphin CAS NO 77614-16-5


Melanotan-1 CAS NO 75921-69-6


Dsip CAS NO 62568-57-4


Humanin CAS NO 330936-69-1


Epitalon CAS NO 307297-39-8


H-Gly-Pro-Hyp-Oh CAS NO 2239-67-0


Ll-37 CAS NO 154947-66-7


Lactoferrin CAS NO 146897-68-9


Selank Peptide CAS NO 129954-34-3


Holo-Transferrin CAS NO 11096-37-0


Hyaluronidase CAS NO 37326-33-3


n-Acetyl-Phe-Octreotide CAS NO 83795-61-3


Nph-Peptide CAS NO 84311-50-2


Hirsutide CAS NO 865368-30-5


Doreptide CAS NO 90104-48-6


Neuropeptide S (1-10) (Human) CAS NO 904910-39-0


Transdermal Peptide CAS NO 918629-48-8


Ha Peptide CAS NO 92000-76-5
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






